NORTHWEST BIOTHERAPEUTICS INC Net Change in Cash
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Net Change in Cash of -$2.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$1.25M, a 307.62% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $604.00K, a 71.59% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $352.00K.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$774.00K.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was $865.00K, a 1665.31% increase from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $49.00K.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$4.84M.
- NORTHWEST BIOTHERAPEUTICS INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$8.20M, a 258.20% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.44M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$1.25M 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $865.00K 10-K · filed 2026-04-15 | |||
| 2025-09-30 | $2.38M 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $2.14M 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $604.00K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $49.00K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $813.00K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $755.00K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $352.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$4.84M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$868.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$5.54M 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | -$774.00K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$8.20M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | -$5.74M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$10.34M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$8.21M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $5.19M 10-K · filed 2024-03-05 | |||
| 2021-09-30 | -$6.15M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$6.22M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | -$2.52M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $9.61M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $8.88M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $5.58M 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $392.00K 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$21.85M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$20.25M 10-Q · filed 2021-01-15 | |||
| 2019-06-30 | -$15.55M 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | -$5.94M 10-Q · filed 2020-06-24 | |||
| 2018-12-31 | $22.11M 10-K · filed 2020-03-16 | |||
| 2018-09-30 | $131.00K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $1.48M 10-Q · filed 2019-08-09 | |||
| 2017-12-31 | -$6.75M 10-K · filed 2018-04-17 | |||
| 2017-09-30 | -$5.82M 10-Q · filed 2017-11-20 | |||
| 2016-12-31 | -$16.18M 10-K · filed 2018-04-17 | |||
| 2016-09-30 | -$21.56M 10-Q · filed 2017-11-20 |